Table 3.
Study | N of Patients with SSI | Kind of Surgery | Most Common Bacteria Detected 1 |
---|---|---|---|
CNISP, 2020 [22] | 190 | Cardiac surgery | S. aureus (43%), CoNS (24%) |
Shibamura-Fujiogi, 2020 [29] | 39 (42 positive cultures gathered, 22 for superficial SSI and 20 for Deep/Organ space SSI)) | Intestinal surgery | Superficial SSI: Enterococci (27%), Staphylociocci (18%), P. aeruginosa (15%), E. coli (9%), E. cloacae (9%), B. fragilis (5%), Others (27%) |
Deep/Organ space SSI: Enterococci (30%), E. coli (20%), C. albicans (15%), P. aeruginosa (15%), Staphylococci (10%), B. fragilis (5%), Others (5%) | |||
Pough, 2020 [27] | 12 | Gastrointestinal surgery | MRSA alone 17%, C. glabrata (16%), P. aeruginosa (16%), MSSA alone 9%, K. pneumoniae (8%), C. albicans (8%), E. cloacae (8%), C. tropicalis (8%) |
Tipper, 2019 [32] | 9 3 | Scoliosis surgery | S. aureus (55%), E. coli (22%), E. faecalis (22%), P. aeruginosa (22%), P. acnes (11%), A. fumigatus (11%), S. epidermidis (11%), |
Furdock, 2020 [33] | 7 | Neuromuscular scoliosis surgery | Polimicrobial (42%), MSSA alone (28%), MRSA alone (14%), unassessed (14%) |
Weiner-Lastinger, 2020 [40] 2 | 2215 3 | Abdominal surgery | E. coli (24.2%), P. aeruginosa (8.2%), S. aureus (7.9%), E. faecalis (7.6%), Enterobacteriacae (6.8%), CoNS (3.1%), |
487 3 | Orthopedic surgery | S. aureus (32.2%), E. coli (10.9%), P. aeruginosa (11.9%), Enterobacteriacae (8.0%), CoNS (7.0%), E. faecalis (2.1%) | |
419 3 | Neurosurgical surgery | S. aureus (27.9%), CoNS (20.5%), P. aeruginosa (7.9%), Enterobacteriacae (7.9%), E. coli (3.6%), E. faecalis (1.2%) | |
312 3 | Cardiac surgery | S. aureus (48.7%), CoNS (17.9%), P. aeruginosa (4.5%), Enterobacteriacae (2.9%), E. faecalis (2.9%), E. coli (1.6%) | |
Lake, 2018 [41] | 3053 3 | Any kind of surgery | S. aureus (22.2%), E. coli (17.5%), CoNS (9.6%), P. aeruginosa (7.6%), Enterobacteriacae (6.2%), E. faecalis (4.5%) |
Woltmann, 2017 [43] | 212 3 (from 2012 to 2015) | Clean or clean-contaminated surgery | MSSA (27%), MRSA (15%), CoNS (14%), P. aeruginosa (9%), Enterobacteriacae (7%), Enterococci (6%), Streptococci (4%) |
286 3 (from 2006 to 2011) | MSSA (28%), MRSA (12%), CoNS (12%), P. aeruginosa (8%), Enterobacteriacae (7%), Enterococci (5%), Streptococci (4%) | ||
420 3 (from 2000 to 2005) | CoNS (25%), MSSA (15%), P. aeruginosa (9%), Enterococci (8%), MRSA (6%), Enterobacteriacae (6%), Streptococci (5%) | ||
323 3 (from 1994 to 1999) | MSSA (17%), CoNS (16%), Enterococci (11%), P. aeruginosa (8%), Enterobacteriacae (11%), Streptococci (5%), MRSA (0%) | ||
Prasad, 2016 [38] | 26 4 | Any kind of surgery on neonates | S. aureus (38%), CoNS (12%), Enterobacteriacae (8%), Yeast (8%), E. faecalis (8%), E. coli (4%) |
Lejus, 2013 [39] | 11 | Any kind of surgery on neonates | MRCoNS (63%), MSSA (18%), MSCoNS (9%), E. cloacae (9%) |
1 Some patients had cultures positive for more than one bacteria species. 2 The prevalence of the 6 most frequent species overall were reported. 3 Number of SSIs reported (specified when it differs from the number of patients in which SSIs were identified or when the number of patients was not specified in the study). 4 Only 26 cultures were obtained out of the 60 SSIs reported by the study. MSSA: methicillin-susceptible S. aureus; MRSA: methicillin-resistant S. aureus; CoNS: Coagulase-negative Staphylococci (MRCoNS and MSCoNS: methicillin-resistant and sensitive, respectively).